Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
107.79
-1.13 (-1.04%)
At close: Aug 20, 2026, 4:00 PM EDT
108.50
+0.71 (0.66%)
Pre-market: Aug 21, 2026, 7:26 AM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $9.5 billion as of August 21, 2026. Its market cap has increased by 876.70% in one year.
Market Cap
9.50B
Enterprise Value
8.36B
1-Year Change
876.70%
Ranking
Category
Stock Price
$107.79
ChartMarket Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $9.50B, an increase of 8,408.73%. That is a compound annual growth rate of 53.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 9.50B | 273.90% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 10.38B |
| Kymera Therapeutics | 10.27B |
| Apogee Therapeutics | 10.17B |
| Krystal Biotech | 9.99B |
| Ionis Pharmaceuticals | 9.92B |
| Summit Therapeutics | 9.92B |
| Protagonist Therapeutics | 9.86B |
| Vaxcyte | 9.18B |